MYC and neoplasm: Given that MYC, not MYCN, is normally expressed in neural crest cells early in chick development, MYCN amplification likely drives aberrant cell specification towards a CNS-like fate to increase tumour aggressiveness, while increased MYC in cells developmentally programmed to express MYC could explain a reduced pathogenicity [55].